Megaphone Eyewire headlines are now available as a weekly podcast! Listen Now

Now Playing

Eyewire TV September 30, 2026 thumbnail

Introduction

story 1 thumbnail

Kodiak Reports Phase 3 Trial Meets Primary Endpoints for Zenkuda in Wet AMD

story 2 thumbnail

European Commission Approves Roche’s Susvimo for Wet AMD

story 3 thumbnail

Merck's Remigromig Meets Primary Endpoint in Phase 2b/3 BRUNELLO Trial for DME


Previous EyewireTV Episodes